跳至主要内容
临床试验/ISRCTN51917813
ISRCTN51917813已完成不适用

An investigation into the effects of cessation of clopidogrel therapy on vascular inflammation and platelet reactivity in patients with drug-eluting coronary stents: is there a rebound phenomenon?

Southampton University Hospitals NHS Trust (UK)0 个研究点目标入组 60 人开始时间: 2010年4月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged greater than 18 years, either sex
  • 2. Signed written informed consent
  • 3. Prior percutaneous coronary intervention (PCI) with drugeluting stent implantation and due to stop clopidogrel 12 months after PCI
  • 4. On maintenance dose aspirin 75 mg and clopidogrel 75 mg daily
  • 5. 30 diabetics and 30 nondiabetics

排除标准

  • 1. Aged greater than 85 years
  • 2. On regular nonsteroidal antiinflammatory medication or steroids

研究者

发起方
Southampton University Hospitals NHS Trust (UK)

相似试验